Claim: AstraZeneca PLC CEO Brennan’s Pay Too High; Spends Too Much on Lobbying

BNET -- British corporate governance watchdog group PIRC is urging AstraZeneca shareholders to vote against management’s annual report and compensation plan because the company gives too much money to U.S. politicians and its top executives.